GRCE Grace Therapeutics, Inc.
Grace Therapeutics, Inc. (GRCE) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: November 18, 2026 , by Opaleye Management Inc. .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner | Buy | 2,974 | $1.73 | $5.1K | 3,102,904 | |
| Opaleye Management Inc. | 10% Owner | Buy | 29,207 | $1.72 | $50.3K | 3,099,930 | |
| Opaleye Management Inc. | 10% Owner | Buy | 15,879 | $1.76 | $28.0K | 3,070,723 | |
| Opaleye Management Inc. | 10% Owner | Buy | 3,087 | $1.77 | $5.5K | 3,054,853 | |
| Opaleye Management Inc. | 10% Owner | Buy | 5,027 | $1.80 | $9.1K | 3,051,766 | |
| Opaleye Management Inc. | 10% Owner | Buy | 10,328 | $1.79 | $18.5K | 3,046,739 | |
| Opaleye Management Inc. | 10% Owner | Buy | 66,411 | $1.77 | $117.4K | 3,036,411 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.